BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34234380)

  • 1. RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis.
    Takeshita A; Nishida K; Yoshida A; Nasu Y; Nakahara R; Kaneda D; Ohashi H; Ozaki T
    PLoS One; 2021; 16(7):e0254268. PubMed ID: 34234380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.
    Martínez-Calatrava MJ; Prieto-Potín I; Roman-Blas JA; Tardio L; Largo R; Herrero-Beaumont G
    Arthritis Res Ther; 2012 Jun; 14(3):R149. PubMed ID: 22709525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
    Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH
    Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
    Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
    BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.
    Revu S; Neregård P; af Klint E; Korotkova M; Catrina AI
    Arthritis Res Ther; 2013; 15(6):R205. PubMed ID: 24295447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
    Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
    Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
    Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
    Skoumal M; Kolarz G; Haberhauer G; Woloszczuk W; Hawa G; Klingler A
    Rheumatol Int; 2005 Nov; 26(1):63-9. PubMed ID: 15889303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
    Nakano K; Okada Y; Saito K; Tanaka Y
    Arthritis Rheum; 2004 Aug; 50(8):2450-8. PubMed ID: 15334457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis.
    Min HK; Kim SH; Lee JY; Lee SH; Kim HR
    Sci Rep; 2022 Jul; 12(1):12767. PubMed ID: 35896699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
    Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH
    Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
    Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H
    Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells.
    Byron CR; Barger AM; Stewart AA; Pondenis HC; Fan TM
    Am J Vet Res; 2010 Jun; 71(6):615-22. PubMed ID: 20513175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.
    Kim JY; Lee EY; Lee EB; Lee YJ; Yoo HJ; Choi J; Song YW
    Arthritis Res Ther; 2012 Aug; 14(4):R187. PubMed ID: 22901757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.